SuperworthBeOne Medicines shares outstanding ONC
Diluted shares outstanding, averaged over each quarter, from 2015.
- Latest quarter, to Jun 30, 2026
- 1.5B
- On a year earlier
- +2.9%
- more shares
BeOne Medicines had 1.5B diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 1.5B | +8% |
| FY2024 | 1.4B | +3% |
| FY2023 | 1.4B | +0% |
| FY2022 | 1.3B | +9% |
| FY2021 | 1.2B | +5% |
| FY2020 | 1.2B | +50% |
| FY2019 | 788.9M | +2% |
| FY2018 | 772M | +31% |
| FY2017 | 590.2M | +27% |
| FY2016 | 463.6M | +282% |
| FY2015 | 121.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 1.5B | +3% | |
| Q1 FY26 | 1.5B | +4% | |
| Q4 FY25 | 1.5B | +8% | |
| Q3 FY25 | 1.5B | +8% | |
| Q2 FY25 | 1.5B | +8% | |
| Q1 FY25 | 1.4B | +7% | |
| Q4 FY24 | 1.4B | +3% | |
| Q3 FY24 | 1.4B | −1% | |
| Q2 FY24 | 1.4B | +0% | |
| Q1 FY24 | 1.4B | +0% | |
| Q4 FY23 | 1.4B | +0% | |
| Q3 FY23 | 1.4B | +3% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on BeOne Medicines
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.